Suppr超能文献

慢性抗抑郁药治疗对大鼠脑单胺能系统的一些影响。

Some effects of chronic antidepressant treatments on rat brain monoaminergic systems.

作者信息

Sugrue M F

出版信息

J Neural Transm. 1983;57(4):281-95. doi: 10.1007/BF01248999.

Abstract

A range of established and putative antidepressant therapies were studied for the effect of their long-term administration on two facets of presynaptic monoaminergic functioning in rat brain, namely NE, DA, and 5-HT turnover and alpha 2-adrenoceptor sensitivity. Unless stated otherwise drugs (10 mg/kg) were injected i.p. twice daily for 14 days. ECT (100 mA for 1 s) was applied once daily for 10 days. Changes in turnover were indirectly assessed by measuring levels of metabolites. Brain levels of MHPG-SO4 were unchanged by chronic amitriptyline, imipramine, nisoxetine (20 mg/kg), nortriptyline, salbutamol (5 mg/kg), and ECT. Amitriptyline elicited a slight, but significant, increase in brain DOPAC content. Brain levels of 5-HIAA were increased by amitriptyline, imipramine, salbutamol, and ECT. An overall view of the results indicates that no common pattern of change was elicited by the range of antidepressant therapies studied. Central alpha 2-adrenoceptor sensitivity was assessed by investigating the effect of various therapies on the ability of clonidine (25 mg/kg i.p.) to decrease rat brain MHPG-SO4 content. The clonidine-induced fall was attenuated by desipramine, imipramine, and ECT. Amitriptyline, iprindole, mianserin, nisoxetine, nortriptyline, Org 6582 (10 mg/kg once daily), pargyline (25 mg/kg once daily), salbutamol, and trazodone were ineffective. The following chronic antidepressant therapies were investigated for their effect on rat frontal cortex 3H-clonidine binding: amitriptyline, desipramine, imipramine, iprindole, mianserin, nisoxetine, nortriptyline, pargyline, salbutamol, and ECT. CHronic, but not acute, pargyline decreased 3H-clonidine binding and this was due to a diminished number of binding sites. The induction of subsensitive presynaptic alpha 2-adrenoceptors in rat brain is not a property common to all forms of antidepressant therapies. Hence it cannot be the fundamental mode of action of antidepressants. No correlation exists between the changes in rat cortical 3H-clonidine binding and the observed changes in the sensitivity of central presynaptic alpha 2-adrenoceptors.

摘要

研究了一系列已确立和推测的抗抑郁疗法,观察它们长期给药对大鼠脑内突触前单胺能功能两个方面的影响,即去甲肾上腺素(NE)、多巴胺(DA)和5-羟色胺(5-HT)的周转以及α2-肾上腺素能受体敏感性。除非另有说明,药物(10毫克/千克)腹腔注射,每日两次,共14天。电休克疗法(100毫安,持续1秒)每天应用一次,共10天。通过测量代谢物水平间接评估周转变化。慢性给予阿米替林、丙咪嗪、尼索西汀(20毫克/千克)、去甲替林、沙丁胺醇(5毫克/千克)和电休克疗法后,脑内3-甲氧基-4-羟基苯乙二醇硫酸酯(MHPG-SO4)水平未发生变化。阿米替林使脑内3,4-二羟基苯乙酸(DOPAC)含量略有但显著增加。阿米替林、丙咪嗪、沙丁胺醇和电休克疗法使脑内5-羟吲哚乙酸(5-HIAA)水平升高。结果的总体情况表明,所研究的一系列抗抑郁疗法未引发共同的变化模式。通过研究各种疗法对可乐定(25毫克/千克腹腔注射)降低大鼠脑内MHPG-SO4含量能力的影响,评估中枢α2-肾上腺素能受体敏感性。地昔帕明、丙咪嗪和电休克疗法减弱了可乐定诱导的降低作用。阿米替林、茚满二酮、米安色林、尼索西汀、去甲替林、Org 6582(每日一次,10毫克/千克)、帕吉林(每日一次,25毫克/千克)、沙丁胺醇和曲唑酮无效。研究了以下慢性抗抑郁疗法对大鼠额叶皮质3H-可乐定结合的影响:阿米替林、地昔帕明、丙咪嗪、茚满二酮、米安色林、尼索西汀、去甲替林、帕吉林、沙丁胺醇和电休克疗法。慢性而非急性给予帕吉林降低了3H-可乐定结合,这是由于结合位点数量减少所致。大鼠脑内诱导突触前α2-肾上腺素能受体低敏并非所有形式抗抑郁疗法共有的特性。因此,它不可能是抗抑郁药的基本作用模式。大鼠皮质3H-可乐定结合的变化与所观察到的中枢突触前α2-肾上腺素能受体敏感性变化之间不存在相关性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验